Vaqta

List of products in the National Drug Code with proprietary name vaqta. This vaccine is used to help prevent infection from the hepatitis A virus. Hepatitis A infection can be mild with no symptoms or a severe illness that can rarely cause liver failure and death. Preventing infection can prevent these problems. Hepatitis A vaccine is made from whole, killed hepatitis A virus. It does not contain live virus, so you cannot get hepatitis from the vaccine. This vaccine works by helping the body produce immunity (through antibody production) that will prevent you from getting infection from hepatitis A virus. Hepatitis A vaccine does not protect you from other virus infections (such as HIV virus, which causes AIDS; hepatitis B, hepatitis C or hepatitis E; HPV virus, which causes genital warts and other problems). The vaccine is recommended for people aged 12 months and older, especially those at an increased risk of getting the infection. Those at an increased risk include people who live with or spend much time with people with hepatitis A infections, institutional or daycare workers, lab workers, people with multiple sex partners, men who have sex with men, sex workers, injecting and non-injecting drug abusers, and people traveling to high-risk areas.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0006-4095Vaqta Hepatitis A Vaccine, InactivatedInjection, SuspensionIntramuscularMerck Sharp & Dohme LlcVaccine
0006-4096Vaqta Hepatitis A Vaccine, InactivatedInjection, SuspensionIntramuscularMerck Sharp & Dohme LlcVaccine
0006-4831Vaqta Hepatitis A Vaccine, InactivatedInjection, SuspensionIntramuscularMerck Sharp & Dohme LlcVaccine
0006-4841Vaqta Hepatitis A Vaccine, InactivatedInjection, SuspensionIntramuscularMerck Sharp & Dohme LlcVaccine